Explore the details of the Boehringer Ingelheim Pharmaceuticals Inc. V. Granules India Limited case under case number 1:24-cv-01091 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:24-cv-01091
Filing Date
Sep 30, 2024
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Boehringer Ingleheim Pharma GMBH & Co. KG -
Granules India Limited -

Patents Involved in the Case

This case involves 5 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Sep 30, 2024Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 08/16/2024. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 2/16/2027. (scs). (Entered: 10/01/2024)PACER Document
Sep 30, 2024Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (scs) (Entered: 10/01/2024)PACER Document
Sep 30, 2024COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Granules India Limited ( Filing fee $ 405, receipt number ADEDC-4511929.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GMBH, and Boehringer Ingelheim Pharma GmbH & Co. KG. (Attachments: # 1 Exhibit 1-5, # 2 Civil Cover Sheet)(scs) (Entered: 10/01/2024)PACER Document
Sep 30, 2024Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C.H. Boehringer Sohn AG & Co. KG. for Boehringer Ingelheim Pharmaceuticals Inc. Filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, and Boehringer Ingelheim Pharma GmbH & Co. KG. (scs) (Entered: 10/01/2024)PACER Document
Sep 30, 2024Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,155,705 B2; 9,415,016 B2; 10,022,379 B2; 10,973,827 B2 ; 11,911,388 B2. (scs) (Entered: 10/01/2024)PACER Document
Sep 30, 2024Summons Issued as to Granules India Limited. (scs) (Entered: 10/01/2024)PACER Document
Oct 2, 2024STANDING ORDER REGARDING BRIEFING IN ALL CASES. Signed by Judge Colm F. Connolly on 10/2/2024. (mws) (Entered: 10/02/2024)PACER Document
Oct 2, 2024Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb)PACER Document